AngioDynamics Inc ANGO
News
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026
AngioDynamics to Participate in Upcoming Investor Conferences